Reactive Arthritis Caused by Haemophilus parainfluenzae in a Diabetic Patient

Eguchi, Tomohiro; Horino, Taro; Amano, Eri; Ichii, Osamu; Terada, Yoshio

doi:10.1016/j.amjmed.2018.11.007

Cited by 3 publications

(2 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Very rarely caused by haemophilus parainluenza. [8] Various components of these organisms have been observed in synovium of the patients with reactive arthritis. HLA-B27 positivity in these patients is directly related to increased severity of reactive arthritis and increased probability of developing various extra-articular manifestations.…”

Section: Discussionmentioning

confidence: 99%

Shigella flexneri associated reactive arthritis - GI transmitted or sexually transmitted?

Kaeley

Kumar

Bhardwaj

et al. 2019

J Family Med Prim Care

View full text Add to dashboard Cite

The pathogenic association of reactive arthritis with human immunodeficiency virus (HIV) needs more attention. In this case report we described a case of 22 year old male patient suffering from severe HIV infection. He presented with the complaints of left knee joint pain associated with swelling and tenderness. He also developed keratotic papules on palms and soles and polycyclic erosions on the glans penis. He was diagnosed as a case of reactive arthritis with HIV infection. The patient was treated with sulfasalazine and anti retroviral therapy. We, hereby discuss the underlying pathogenesis and treatment modalities in patients of reactive arthritis with underlying HIV infection. The treatment of reactive arthritis with HIV is a challenge due to limited options of immunosupressive agents.

show abstract

Section: Discussionmentioning

confidence: 99%

Shigella flexneri associated reactive arthritis - GI transmitted or sexually transmitted?

Kaeley

Kumar

Bhardwaj

et al. 2019

J Family Med Prim Care

View full text Add to dashboard Cite

show abstract

“…We analyzed 14 case reports and four large-scale studies that are pertinent for our discussion. The case reports and the large studies are displayed in Table 4 [3][4][5][6][7][8][9][10][11][12][13][14][15][16] and Table 5 [17][18][19][20], respectively. We risk-stratified the case reports by poor prognostic factors and analyzed the treatment options in the order they were used in each case study.…”

Section: Organ Involvement Typical Clinical Presentationsmentioning

confidence: 99%

Approaching Reactive Arthritis Associated With Poor Prognostic Factors: A Case Report and Literature Review

Alexander

Kim

Mandhadi

2021

Cureus

View full text Add to dashboard Cite

The aim of this paper is to review and discuss the background, common manifestations, differential diagnosis, and current treatment practices of reactive arthritis. The focus will be on the choice of therapy in patients with poor prognostic factors. A PubMed search was performed in March 2020 on reactive arthritis and revealed 137 articles. Fourteen case reports and four large-scale studies that are pertinent for discussion in terms of treatment of reactive arthritis over the past five years are reported along with poor prognostic markers. The first choice of therapy regardless of the number of poor prognostic markers is non-steroidal anti-inflammatory drugs (NSAIDs). The second choice of therapy appeared to be glucocorticoids in the oral as well as intra-articular forms. No correlation was detected between the need for systemic steroids and the number of poor prognostic factors present. The third choice of therapy appears to be disease-modifying antirheumatic drugs (DMARDs) (such as sulfasalazine) and their increasing use can be demonstrated over time. Novel therapies such as adalimumab have also been shown to be used and this shows a strong correlation with an increased number of poor prognostic factors. Reporting of these case reports and review of literature contribute to knowing more about reactive arthritis and help keep us up to date with newer therapies available when patients do not respond to conventional therapy. It was notable that the increased number of poor prognostic factors and non-responders have shown increased use of tumor necrosis factor inhibitors (TNFI) such as adalimumab.

show abstract

Evaluation of clinical and paraclinical findings in patients with reactive arthritis caused by giardiasis: A systematic review

Mahdavi

Motavallihaghi

Ghasemikhah

2022

Seminars in Arthritis and Rheumatism

View full text Add to dashboard Cite

Reactive Arthritis Caused by Haemophilus parainfluenzae in a Diabetic Patient

Cited by 3 publications

References 2 publications

Shigella flexneri associated reactive arthritis - GI transmitted or sexually transmitted?

Shigella flexneri associated reactive arthritis - GI transmitted or sexually transmitted?

Approaching Reactive Arthritis Associated With Poor Prognostic Factors: A Case Report and Literature Review

Evaluation of clinical and paraclinical findings in patients with reactive arthritis caused by giardiasis: A systematic review

Contact Info

Product

Resources

About